Skip to main content

Neurotech Reports

News

Mobia Medical: from Application Evolution to IPO to Commercialization   

Formerly known as MicroTransponder, Austin, TX-based Mobia Medical is commercializing Vivistim, an implanted vagus nerve stimulation system indicated for use during rehabilitation therapy to reduce upper-extremity motor deficits and improve motor function in chronic ischemic stroke patients with moderate to severe arm impairment. 

MIT Microscope Offers a Faster Look at Whole-Brain Electrical Activity 

A new high-speed microscope from MIT could give neuroscientists a more direct way to observe how neurons communicate across an entire brain—an advance with implications for basic neuroscience, neurotechnology tool development, and future efforts to map distributed neural circuits in real time. 

Neuromodulation Therapies Progress for the Treatment of Drug-Resistant Epilepsy  

Over the past two decades, neuromodulation for drug-resistant epilepsy (DRE) has evolved from a single approved therapy—vagus nerve stimulation—into a broader field that includes responsive neurostimulation, deep brain stimulation, less-invasive cortical stimulation and emerging optical, thermal, and sensing-enabled systems. Antiseizure medications remain the first-line treatment, but approximately one-third of people with epilepsy continue to experience seizures despite pharmacologic therapy, creating a substantial unmet clinical need.  

Computer Vision is Becoming Neurotech’s Situational Understanding Layer and Distribution Channel 

Machine Medicine’s FDA breakthrough designation for their video assessment platform, hiring at Metamorphic and Epia Neuro, and a leaked Apple AirPods demo all point to the same patterns: computer vision can give better situational understanding and standardization in a world where human raters find challenges with consistency. Because cameras, LiDAR, and other types of spatial sensor systems are becoming inexpensive and ubiquitous, computer vision systems are increasingly easier to implement both in research settings and in everyday life. 

Reach Neuro Reaches New Heights 

Reach Neuro’s job board is empty for the moment. That is not an indication of the growth stage of the company. In fact, one could argue that the recent hiring of Jennifer Ernst as the firm’s new chief executive officer and engaging Jordi Parramon as the chairman of the board of directors is a signal that this is the calm before the storm. In fact, one of the stated goals in their current $1.5 million seed-round funding pitch calls for building a “Series A Fundable Team.” 

Lehigh Team Uses Digital Twin of Gut-Brain Axis to Advance Neurostimulation Therapies 

A team of researchers at Lehigh University has developed one of the first comprehensive mathematical models of the neural circuitry linking the gut and brain, a “digital twin” designed to simulate how bidirectional signaling regulates stomach function. The work, described in Frontiers in Physiology, could help bioelectronic medicine researchers understand disorders of gut-brain interaction and accelerate the development of neuromodulation therapies such as vagus nerve stimulation. 

Briefings from Epitel, Neurolief, ReVision, Aurenar, More  

News from across the neurotech and bioelectronic medicine sector including funding for wireless EEG, 25 years of Implanted Pulse Generators, new patents for Autonomix, Transcutaneous Auricular Neurostimulation for menstrual bleeding, Percutaneous Electrical Nerve Field Stimulation, funding updates, and more.   

Maria Bennett Shares Insights from SPR/Medtronic Merger  

Earlier this summer, Medtronic announced that it completed its acquisition of SPR Therapeutics, Inc., the Cleveland, OH manufacturer of peripheral nerve stimulation systems for treating pain. The acquisition is valued at $650 million. NBR editor James Cavuoto sat down with SPR founder and CEO Maria Bennett at the recent meeting of the American Society of Pain and Neuroscience in Miami.  

Neurotech Events

Neurotech Leaders Forum

November 9-10, 2026 | San Francisco, CA


Bioelectronic Medicine Forum

April 13, 2027 | New York City, NY


European Neurotech Leaders Forum

June 23-24, 2026 | Leuven, Belgium